Mark Millard is a Respiratory physician affiliated with Baylor College of Medicine. OpenAlex indexes 57 publications with 1,203 citations (h-index 14); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4004 Worth St
Suite 300
Dallas, TX 75246
Telephone
214-820-3500Provider last certified this registry record 5 Jul 2023.
Clinical trials
- Outcomes of Once-Daily ICS/LABA/LAMA + PRN Respiratory Therapy Treatments in Hospitalized Patients With COPD Exacerbations
Sponsor: Baylor Research Institute
- Harmonica Playing Improves Quality of Life in Patients With COPD
Sponsor: Baylor Research Institute
- Breathing Training for Asthma
Sponsor: Southern Methodist University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202516 payments
- GlaxoSmithKline, LLC.Program year202522 payments
- Insmed, Inc.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Intensity of CD23 expression on IgG1+ B cells reflects serum IgE level in asthma
Journal of Allergy and Clinical Immunology Global
2025 - Effect of a Self-Directed Lifestyle-based Weight Management Program Among Patients With Comorbid COPD and Sleep Apnea
American Journal of Respiratory and Critical Care Medicine
2025 - Establishing Outcomes of Once-daily Triple Therapy Plus as Needed Albuterol in Hospitalized Patients With COPD Exacerbations: The SUNDIAL-COPD Study
American Journal of Respiratory and Critical Care Medicine
2025 - Omalizumab is ineffective in regulating proasthmatic serum cytokine and chemokine levels in nonresponders with high BMI
Journal of Allergy and Clinical Immunology Global
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Christie Ballantyne, MD
Baylor College of Medicine
Biykem Bozkurt, MD
Baylor College of Medicine
Malcolm Brenner, MD
Baylor College of Medicine
Garabed Eknoyan, MD
Baylor College of Medicine
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”